2-165295929-A-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_001040142.2(SCN2A):c.106A>G(p.Arg36Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000684 in 1,461,850 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001040142.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN2A | ENST00000375437.7 | c.106A>G | p.Arg36Gly | missense_variant | Exon 2 of 27 | 5 | NM_001040142.2 | ENSP00000364586.2 | ||
SCN2A | ENST00000631182.3 | c.106A>G | p.Arg36Gly | missense_variant | Exon 2 of 27 | 5 | NM_001371246.1 | ENSP00000486885.1 | ||
SCN2A | ENST00000283256.10 | c.106A>G | p.Arg36Gly | missense_variant | Exon 2 of 27 | 1 | ENSP00000283256.6 | |||
SCN2A | ENST00000424833.5 | c.106A>G | p.Arg36Gly | missense_variant | Exon 2 of 11 | 1 | ENSP00000406454.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251154Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135734
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461850Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727220
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Seizures, benign familial infantile, 3;C3150987:Developmental and epileptic encephalopathy, 11 Uncertain:2
- -
This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 36 of the SCN2A protein (p.Arg36Gly). This variant is present in population databases (rs796053167, gnomAD 0.0009%). This missense change has been observed in individuals with early-onset seizures (PMID: 28379373, 30619928). ClinVar contains an entry for this variant (Variation ID: 207035). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SCN2A protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Reported as a maternally inherited variant in two unrelated patients with benign familial neonatal seizures (Wolff et al., 2017); Reported previously in a patient with neonatal seizures, however information about parental testing was not provided (Kong et al., 2019); Not observed at significant frequency in large population cohorts (gnomAD); This substitution is predicted to be within the N-terminal cytoplasmic domain; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variants in this gene are often considered pathogenic (HGMD); This variant is associated with the following publications: (PMID: 35637276, 33731876, 30619928, 28379373) -
Complex neurodevelopmental disorder Uncertain:1
Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2019-03-18 and interpreted as Variant of Uncertain significance. Variant was initially reported on 2014-04-03 by GTR ID of laboratory name 26957. The reporting laboratory might also submit to ClinVar. Variant was identified in multiple siblings. Additional phenotypic information for other sibling(s) might be available from Simons Searchlight. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at